Stem cell transplant and Deep venous thrombosis

Summary:

Deep venous thrombosis is found among people with Stem cell transplant, especially for people who are male, 50-59 old.

The study analyzes which people have Deep venous thrombosis with Stem cell transplant. It is created by eHealthMe based on reports of 50 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 431 drugs and 383 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,070 drugs and 2,962 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Jul, 11, 2026

50 people who have Stem Cell Transplant and Deep Venous Thrombosis are studied.

Would you have Deep venous thrombosis when you have Stem cell transplant?

Gender of people who have Stem Cell Transplant and experienced Deep Venous Thrombosis *:

female: 18.42 %
male: 81.58 %

Age of people who have Stem Cell Transplant and experienced Deep Venous Thrombosis *:

Common co-existing conditions for these people *:

Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 8 people, 16.00%
Multiple Myeloma (cancer of the plasma cells): 7 people, 14.00%
Bone Marrow Conditioning Regimen: 7 people, 14.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 10.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 10.00%
Glomerulonephritis Minimal Lesion (a disease of the kidney that causes nephrotic syndrome and usually affects children): 4 people, 8.00%
Type 2 Diabetes: 3 people, 6.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 6.00%
Immunodeficiency Disorders: 3 people, 6.00%
Apheresis: 2 people, 4.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Thrombocytopenia (decrease of platelets in blood): 17 people, 34.00%
Anaemia (lack of blood): 14 people, 28.00%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 13 people, 26.00%
Cytomegalovirus Infection: 12 people, 24.00%
High Blood Cholesterol: 11 people, 22.00%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 11 people, 22.00%
Dry Eyes (lack of adequate tears): 11 people, 22.00%
Meningioma (a diverse set of tumours arising from the meninges): 11 people, 22.00%
Renal Tubular Necrosis (death of kidney tubules): 11 people, 22.00%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 11 people, 22.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Deep venous thrombosis and Stem cell transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.